The G-Protein-Coupled Estrogen Receptor Agonist G-1 Mediates Antitumor Effects by Activating Apoptosis Pathways and Regulating Migration and Invasion in Cervical Cancer Cells
Abigail Gaxiola-Rubio(Universidad de Guadalajara), Ana Laura Pereira-Suárez(Universidad de Guadalajara), Julio César Villegas‐Pineda(Universidad de Guadalajara), Adrián Ramírez-de-Arellano(Universidad de Guadalajara), Moisés Ramos‐Solano(Universidad de Guadalajara), Christian David Hernández-Silva(Universidad de Guadalajara), Luis Felipe Jave‐Suárez(Mexican Social Security Institute), Marisa de Jesús Lizárraga-Ledesma(Universidad de Guadalajara), Carlos Daniel Díaz-Palomera(Universidad de Guadalajara)
Cited by 5
Related Papers
Expression and Role of the G Protein-Coupled Estrogen Receptor (GPR30/GPER) in the Development and Immune Response in Female Reproductive Cancers
|Frontiers in Endocrinology|2020|73
The Relevant Participation of Prolactin in the Genesis and Progression of Gynecological Cancers
|Frontiers in Endocrinology|2021|28
HPV and Cervical Cancer: Molecular and Immunological Aspects, Epidemiology and Effect of Vaccination in Latin American Women
|Viruses|2024|26
Interaction between 17β-estradiol, prolactin and human papillomavirus induce E6/E7 transcript and modulate the expression and localization of hormonal receptors
|Cancer Cell International|2019|25
STAT3 activation is required for the antiapoptotic effects of prolactin in cervical cancer cells
|Cancer Cell International|2015|24